KDELR2 and non-small cell lung carcinoma: Furthermore, KDELR2 has been reported to be overexpressed in metastatic non-small cell lung cancer (NSCLC) cells and bladder cancer, where it enhances Golgi-mediated release of matrix metalloproteinases (MMPs) to drive ECM invasion (Fig. 2) [29, 30].